Close

Genomic Health (GHDX) Reports In-Line Q2 EPS

August 2, 2016 4:43 PM EDT
Get Alerts GHDX Hot Sheet
Price: $63.44 --0%

Financial Fact:
Income tax expense: 464K

Today's EPS Names:
FSI, RELV, NEOM, More
Join SI Premium – FREE

Genomic Health (NASDAQ: GHDX) reported Q2 EPS of ($0.18), in-line with the analyst estimate of ($0.18). Revenue for the quarter came in at $82 million versus the consensus estimate of $81.27 million.

GUIDANCE:

Genomic Health sees FY2016 EPS of ($0.37)-($0.55), versus the consensus of ($0.45). Genomic Health sees FY2016 revenue of $325-335 million, versus prior guidance of $320-335 million and the consensus of $330.5 million.

For earnings history and earnings-related data on Genomic Health (GHDX) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings